PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d\'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.\', \'Department of Virology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France.\', \'Team \'Viruses, Hepatology, Cancer,\' Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciab492
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34050731
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all